Revium Recovery Inc
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors. The company specializes in infectious diseases, including antibiotic-resistant infections, solid tumors and vaccination. The compa… Read more
Revium Recovery Inc (RVRC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.037x
Based on the latest financial reports, Revium Recovery Inc (RVRC) has a cash flow conversion efficiency ratio of -0.037x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-692.00K) by net assets ($18.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Revium Recovery Inc - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Revium Recovery Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Revium Recovery Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Revium Recovery Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BEYOND MED TEC. INC. NEW
F:7FM
|
N/A |
|
Nupur Recyclers Limited
NSE:NRL
|
0.138x |
|
Banimmo S.A.
LSE:0NG8
|
-0.063x |
|
Metro Systems Corporation Public Company Limited
BK:MSC
|
-0.075x |
|
Shalimar Paints Limited
NSE:SHALPAINTS
|
-0.010x |
|
Pacific Orient Bhd
KLSE:6009
|
-0.205x |
|
The Practical Solution Public Company Limited
BK:TPS
|
0.173x |
|
Nosa Med AB
ST:NOSA
|
-0.054x |
Annual Cash Flow Conversion Efficiency for Revium Recovery Inc (2020–2024)
The table below shows the annual cash flow conversion efficiency of Revium Recovery Inc from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $18.79 Million | $-1.21 Million | -0.064x | +43.79% |
| 2023-12-31 | $5.49 Million | $-629.00K | -0.115x | +94.55% |
| 2022-12-31 | $390.00K | $-821.00K | -2.105x | -109.84% |
| 2021-12-31 | $936.00K | $-939.00K | -1.003x | -219.85% |
| 2020-12-31 | $1.25 Million | $-393.00K | -0.314x | -- |